Korean Lawmakers Propose Health Ministry Split Amid MERS Woes
This article was originally published in PharmAsia News
As the impact of the MERS outbreak reverberates throughout South Korea, and amid mounting criticism over how the government - especially the Ministry of Health and Welfare - has handled the crisis situation, lawmakers have proposed a bill to split the ministry in two. This would enable each part to better focus on its specialty and better handle relevant matters, it is claimed.
You may also be interested in...
Hanmi licenses out GLP-1/glucagon receptor dual agonist for NASH to Merck, in a deal worth up to $870m, marking a positive turn for the Korean firm's pipeline after Janssen returned rights last year.
Private Company Edition: Several drug developers targeting neurological diseases raised venture capital recently. In addition to Nura Bio, Encoded Therapeutics revealed a $135m series D round. Also, Longwood closed a $170m fund and Flagship launched Omega Therapeutics with $85m.